Organigram Global (OGI) Receivables - Net (2018 - 2025)
Organigram Global (OGI) posted quarterly Receivables - Net of $47.1 million for Q3 2025, up 73.04% year-on-year from $27.2 million in Q3 2024, and up 73.04% on a QoQ basis from $27.2 million in Q3 2024.
Organigram Global (OGI) Receivables - Net (2018 - 2025) Analysis & Trends
Organigram Global (OGI) has reported Receivables - Net for 8 consecutive years, with $47.1 million the latest figure, recorded in Q3 2025.
- Quarterly Receivables - Net rose 73.04% year-over-year to $47.1 million in Q3 2025, while the trailing twelve-month figure through Sep 2025 was $47.1 million (up 73.04% YoY) and the FY2025 annual result came in at $47.1 million, up 73.04% from the prior year.
- Receivables - Net grew to $47.1 million in Q3 2025 per OGI's latest filing, from $27.2 million in the prior quarter.
- Over the last five years, Receivables - Net for OGI reached as high as $47.1 million in Q3 2025 and fell as low as $10.6 million in Q1 2021.
- A 5-year average of $25.0 million and a median of $24.3 million in 2021 frame the typical range for Receivables - Net.
- Annual changes were most pronounced in 2021 — Receivables - Net plunged 48.79% — and 2022, when it soared 109.54%.
- Year by year, Receivables - Net stood at $26.1 million in 2021, then jumped by 30.44% to $34.1 million in 2022, then slumped by 33.95% to $22.5 million in 2023, then climbed by 21.07% to $27.2 million in 2024, then surged by 73.04% to $47.1 million in 2025.
- According to Business Quant data, Receivables - Net over the past three periods registered $47.1 million, $27.2 million, and $22.5 million for Q3 2025, Q3 2024, and Q3 2023 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Organigram Global | 89.89 Mn | 122.96 Mn | 28.97 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 47.13 Mn |
| Sep 30, 2025 | 47.13 Mn |
| Sep 30, 2024 | 27.24 Mn |
| Sep 30, 2024 | 27.24 Mn |
| Sep 30, 2023 | 22.50 Mn |
| Sep 30, 2023 | 22.50 Mn |
| Aug 31, 2022 | 34.06 Mn |
| Aug 31, 2022 | 34.06 Mn |
| Nov 30, 2021 | 26.11 Mn |
| Nov 30, 2021 | 26.11 Mn |
| Aug 31, 2021 | 16.25 Mn |
| Aug 31, 2021 | 16.25 Mn |
| May 31, 2021 | 16.29 Mn |
| May 31, 2021 | 16.29 Mn |
| Feb 28, 2021 | 10.56 Mn |
| Feb 28, 2021 | 10.56 Mn |
| Nov 30, 2020 | 12.84 Mn |
| Nov 30, 2020 | 12.84 Mn |
| Aug 31, 2020 | 8.26 Mn |
| Aug 31, 2020 | 8.26 Mn |